Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/15/1994 | US5364862 Adenosine derivatives |
11/15/1994 | US5364860 Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions |
11/15/1994 | US5364857 Cerebral antiischaemic agents, chroman and fluorophenyl compound |
11/15/1994 | US5364856 Modification of serotonin function |
11/15/1994 | US5364855 Cardiovascular disorders or antiarrthmia agents |
11/15/1994 | US5364853 Treatment of disorders associated with vascular, respiratory, gastrointestinal tract, urinary bladder or uterus smooth muscle contraction |
11/15/1994 | US5364652 Potato starch treated with heat and hydrochloric acid and hydrolyzed with amylase and glucoamylase; dietetics; fibers; foods |
11/15/1994 | US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis |
11/14/1994 | CA2123243A1 Substituted mono- and bipyridylmethylpyridones |
11/13/1994 | CA2123267A1 Substituted indoles, process for their preparation and pharmaceutical compositions containing them |
11/13/1994 | CA2123162A1 4-substituted benzopyran and related compounds |
11/12/1994 | CA2123163A1 Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
11/11/1994 | CA2121567A1 Substituted pyrroles |
11/10/1994 | WO1994025582A1 Method of enhancing thrombolysis |
11/10/1994 | WO1994025479A1 Spirostanyl glycosidal crystalline monohydrate |
11/10/1994 | WO1994025472A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
11/10/1994 | WO1994025459A1 Heterocyclic derivatives |
11/10/1994 | WO1994025073A1 Recombinant viruses and their use in gene therapy |
11/10/1994 | WO1994025056A2 Use of platelet-derived growth factor to improve collateral circulation |
11/10/1994 | WO1994025049A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
11/10/1994 | WO1994025043A1 Peptides and compounds that bind to elam-1 |
11/10/1994 | WO1994025031A1 An exercise hydration regimen to enhance exercise endurance and performance |
11/10/1994 | WO1994025026A1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
11/10/1994 | WO1994025023A1 Use of indole derivatives as 5ht1 antagonists |
11/10/1994 | WO1994025017A1 PERNASAL PREPARATION COMPRISING threo-3-(3,4-DIHYDROXYPHENYL)SERINE |
11/10/1994 | WO1994025013A1 Endothelin receptor antagonists |
11/10/1994 | WO1994025003A1 Nasal aromatic releasing compositions |
11/10/1994 | WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof |
11/10/1994 | CA2161679A1 Recombinant virus and their use in genic therapy |
11/10/1994 | CA2161669A1 Use of platelet-derived growth factor to improve collateral circulation |
11/10/1994 | CA2161427A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
11/10/1994 | CA2161239A1 Spirostanyl glycosidal crystalline monohydrate |
11/10/1994 | CA2161216A1 Amidino and guanidino substituted boronic acid inhibitors of tryspin-like enzymes |
11/10/1994 | CA2161116A1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
11/10/1994 | CA2160914A1 Endothelin receptor antagonists |
11/10/1994 | CA2160795A1 Heterocyclic derivatives |
11/10/1994 | CA2159508A1 Method of enhancing thrombolysis |
11/09/1994 | EP0623627A1 Sulfonamide derivatives |
11/09/1994 | EP0623625A1 Aminophosphonic acid derivative |
11/09/1994 | EP0623615A1 Adhesion-receptor antagonists |
11/09/1994 | EP0623612A1 Terazosin polymorph and pharmaceutical composition |
11/09/1994 | EP0623611A1 Pyridinylmethyl substituted pyridines and pyridones as Angiotensine II antagonists |
11/09/1994 | EP0623610A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines as Angiotensine II antagonists |
11/09/1994 | EP0623603A1 Styrene derivative and salts thereof |
11/09/1994 | EP0623596A1 N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors |
11/09/1994 | EP0623350A1 Use of Bradykinin-antagonists for the manufacture of a medicament for the prophylaxis and treatment of arteriosclerosis |
11/09/1994 | EP0623348A1 The use of AICA riboside and ribavirin for the preparation of a medicament for the treatment of allergies |
11/09/1994 | EP0623144A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
11/09/1994 | EP0623143A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
11/09/1994 | EP0623133A1 Substituted amino alkyl compounds |
11/09/1994 | EP0623126A1 Imidazole derivatives and their use as cytokine inhibitors |
11/09/1994 | EP0623120A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
11/09/1994 | EP0623116A1 Amino acid derivatives as paf-receptor antagonists |
11/09/1994 | EP0623112A1 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
11/09/1994 | EP0623111A1 Nitroquinolone derivatives as nmda antagonists |
11/09/1994 | EP0623020A1 Pyropheophorbides and their use in photodynamic therapy |
11/09/1994 | EP0623019A1 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
11/09/1994 | EP0576452B1 Products containing verapamil and trandolapril |
11/09/1994 | EP0420937B1 Therapeutic compositions for the treatment of myocardial infarction |
11/09/1994 | EP0380588B1 Certain 3-substituted 2-alkyl benzofuran derivatives |
11/09/1994 | CN1094727A 5-arylindole derivatives |
11/09/1994 | CN1094724A 6-heterocyclic-4-amino1,3,4,5-tetrahydrobenzÛCDÙindoles for treating motion sickness and vomiting |
11/09/1994 | CN1094722A Novel treatment |
11/09/1994 | CN1094613A Novel treatment |
11/09/1994 | CN1094577A Magnetotherapeutic food and preparing process thereof |
11/08/1994 | US5362915 Inhibitors of enzymes/hydrolases; antiallergens, antiinflammatory agents |
11/08/1994 | US5362902 Diuretics and treatment of cardiovascular disorders |
11/08/1994 | US5362757 Administering for treatment of cardiovascular disorders while reducing side effects |
11/08/1994 | US5362742 Quinoline derivatives, their production and use as ACAT inhibitors |
11/08/1994 | US5362735 Fungicides, immunosuppresants, antitumor agents |
11/08/1994 | US5362733 Lipid peroxidation prevention |
11/08/1994 | US5362730 Solvent extraction for compounds for treatment of hypertension |
11/08/1994 | US5362727 Treatment of cardiovascular disorders |
11/08/1994 | US5362718 Antibody inhibitors, antiinflammatory agents, fungicides, antitumor agents |
11/08/1994 | CA2123057A1 Quinoline derivatives with pharmacological activity |
11/08/1994 | CA2122965A1 Substituted benzodioxines, process for their preparation and pharmaceutical compositions containing them |
11/08/1994 | CA2122960A1 Polycyclic compounds and processes for the preparation thereof |
11/08/1994 | CA1332943C Process for preparing perhydrothiazepine derivatives |
11/07/1994 | CA2122790A1 Pyridinylmethyl-substituted pyridines and pyridones |
11/07/1994 | CA2122789A1 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
11/04/1994 | CA2122646A1 Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors |
11/02/1994 | EP0622458A2 Adrenomedullin |
11/02/1994 | EP0622369A2 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof |
11/02/1994 | EP0622368A1 Quinolyl-dihydropyridine esters for treatment of cardio-circulatory diseases |
11/02/1994 | EP0622366A1 Condensed quinolyl-dihydropyridines, process for their preparation and their use in medicine for the treatment of heart-circulatory illnesses |
11/02/1994 | EP0622365A1 2-Amino-4-heteroaryl-1,4-dihydropyridines, method for their preparation and their use in drugs |
11/02/1994 | EP0622358A1 Phenylglycinamides of 4-imidazolylmethyl-phenyl-acetic acids and their use against hypertension and atherosclerosis |
11/02/1994 | EP0622076A1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
11/02/1994 | EP0622075A1 Transdermal delivery of active drugs |
11/02/1994 | EP0621895A1 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
11/02/1994 | EP0621867A1 New endothelin antagonists and their preparation |
11/02/1994 | CN1094404A Heterocyclic compounds |
11/02/1994 | CN1094283A Method of lowering cholesterol |
11/01/1994 | US5360925 Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
11/01/1994 | US5360812 Fused 1,2,5-oxadiazole-2-oxides and their use |
11/01/1994 | US5360809 Imidazole compounds and their use as calcium channel blockers |
11/01/1994 | US5360808 Arylcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use |
11/01/1994 | US5360804 Multicomponent agent or kit for preparing the sulpho-conjugated form of pyridino, pyrimidino or triazino N-oxide compounds and method of use |
11/01/1994 | CA1332808C Polyester-based composition for the controlled release of medicinal substances |
10/30/1994 | CA2122429A1 Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis of treatment of arteriosclerosis |